Mictonorm Xl 30 Mg (Propiverine Hydrochloride)

Propiverine works by competitively blocking muscarinic M3 receptors in the detrusor muscle of the bladder. This antagonism reduces involuntary muscle contractions, allowing the bladder to hold more urine and decreasing the urgency and frequency of voiding.

The prescribed dose of Mictonorm XL 30 mg is determined by the treating physician based on the individual’s clinical condition and response. While many clinicians start with one 30 mg extended‑release tablet taken once daily, the exact regimen should be confirmed with a healthcare professional.

Safety of propiverine during pregnancy and lactation has not been established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To order Mictonorm XL 30 mg, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mictonorm XL (propiverine) offers a once‑daily extended‑release formulation, which can improve adherence compared with multiple‑daily‑dose agents such as oxybutynin. Propiverine also has a slightly different receptor affinity profile, potentially resulting in a lower incidence of dry mouth for some patients, though individual response varies.

Mictonorm XL tablets should be stored at ambient temperature, below 25 °C, in the original blister pack to protect from moisture and light. Keep the medication out of reach of children and do not use after the expiry date printed on the packaging.

Mictonorm XL is taken orally as a whole extended‑release tablet. Swallow the tablet whole with a glass of water; do not split, chew, or crush it, as this may affect the controlled release of the active ingredient.

Serious risks include acute urinary retention that may require catheterisation, severe allergic reactions such as anaphylaxis, and angle‑closure glaucoma, which can lead to vision loss. Patients should seek immediate medical attention if they experience sudden inability to urinate, severe eye pain, or signs of an allergic reaction.

Mictonorm XL should be avoided in patients with known hypersensitivity to propiverine or any excipients, those with uncontrolled narrow‑angle glaucoma, significant urinary retention, or severe hepatic impairment. It is also contraindicated in individuals where anticholinergic therapy is medically prohibited.